Sawhney Roger 4
4 · Omega Therapeutics, Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Sawhney Roger
Chief Financial Officer
Transactions
- Award
Option (Right to Buy)
2022-03-09+60,000→ 60,000 totalExercise: $10.34Exp: 2032-03-08→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable with respect to 25% of the underlying shares on March 9, 2023 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 9, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.